Tactile Systems Technology, Inc. (TCMD): Market Cap to Revenue

Symbol and logo of brand Tactile Systems Technology Inc. (TCMD)

Tactile Systems Technology (TCMD) minimizes manufacturing defects and waste, maintaining its market position through patents and insurance reimbursements. On GURU.Markets, the P/S ratio line chart captures the impact of these factors, where 1.70 serves as the final level marker. The company is currently focusing on implementing digital services for lymphedema treatment monitoring while expanding its line of pneumatic systems.

TCMD Tactile Systems Technology Inc. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Tactile Systems Technology (TCMD)

- share price and consensus valuation forecast:
General company analysis:TCMD Tactile Systems Technology, Inc.
Core merchandise of Tactile Medical

When assessing the asset quality of Tactile Systems Technology (TCMD), it is essential to consider the high level of protection within their market niche provided by patents for lymphedema treatment systems. By analyzing the P/S multiple trend, an investor determines the market value of one dollar of revenue, which allows for an assessment of the premium attributed to insurmountable barriers to entry in the medtech sector and prevents unjustified capital overvaluation at the peak of the trend.

Competitors of Tactile Systems Technology

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|SNWV - Price-to-Revenue Ratio|OM: Price-to-Revenue Ratio|ELMD (smartvest.com) - Market Cap to Revenue|LENSAR Inc - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA (Profusa Inc) - Market Cap to Revenue|SSKN: Market Cap to Sales Volume|GCTK (GlucoTrack, Inc.) - P/S Multiple|P/S Multiple nanovibronix.com|P/S Multiple VERO|Market Cap to Revenue Nuwellis Corp NUWE|Aethlon Medical - Market Cap to Revenue|Market Cap to Sales Volume ASXC (Asensus Surgical Inc)|Avinger - P/S Multiple|Price-to-Revenue Coefficient BioSig BSGM|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|KNW (Know Labs Corporation) - Price-to-Revenue Ratio|NARI (Inari Medical, Inc.) - P/S Multiple|Price to Sales nevro.com NVRO|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio